Research & Safety Studies
Learn more about the efficacy and safety of Prevagen.
The unique ingredient in Prevagen, apoaequorin, was originally found in jellyfish and has been clinically shown to be safe and improve memory and support brain function based on the studies below.*
Madison Memory Study
In a double-blinded, placebo-controlled trial, Prevagen demonstrated the ability to improve aspects of cognitive function in subgroups of participants with either normal cognitive aging or very mild impairment, as determined by pre-trial screening. The group of participants taking Prevagen improved certain aspects of cognitive function according to computer-based testing. The adults were over 40 years old and took one capsule daily (10 mg) for 90 days.
Safety Study I
The unique ingredient in Prevagen, apoaequorin, was evaluated for safety using a toxicity study, a common method for evaluating dietary supplements. Apoaequorin has been found to be safely consumed in doses much higher than recommended dosage (4,000 times the recommended daily amount of Prevagen Regular Strength).
Safety Study II
In a separate safety study, Apoaequorin has not shown to have any significant risk of allergic reactivity when ingested.
Safety Study III
In a third study conducted on the safety of apoaequorin, the protocol followed was very similar to Safety Study I, however, in this instance, the dosage was increased. Apoaequorin has been found to be safely consumed in doses much higher than recommended dosage (16,000 times the recommended daily amount of Prevagen Regular Strength).